Y. Arime

Animal models of attention-deficit/hyperactivity disorder.

I. Sora, Y. Kubo, Y. Arime, 2011, Biological & pharmaceutical bulletin.

Effects of background mutations and single nucleotide polymorphisms (SNPs) on the Disc1 L100P behavioral phenotype associated with schizophrenia in mice

S. Wakana, Y. Gondo, A. Yoshiki, 2014, Behavioral and Brain Functions.

Abnormal neural activation patterns underlying working memory impairment in chronic phencyclidine-treated mice

K. Akiyama, Y. Arime, 2017, PloS one.

Cortico-Subcortical Neuromodulation Involved in the Amelioration of Prepulse Inhibition Deficits in Dopamine Transporter Knockout Mice

I. Sora, G. Uhl, Y. Kasahara, 2012, Neuropsychopharmacology.

Contribution of Translational Genetic Research to Our Understanding of Nicotine Dependence

I. Sora, F. Hall, Y. Saber, 2017 .

Impaired spatial working memory and decreased frontal cortex BDNF protein level in dopamine transporter knockout mice.

I. Sora, G. Uhl, Bingjin Li, 2010, European journal of pharmacology.

Activation of prefrontal parvalbumin interneurons ameliorates treatment-resistant working memory deficit even under continuous antipsychotic treatment in a mouse model of schizophrenia

K. Takao, K. Akiyama, Noriaki Ohkawa, 2023, bioRxiv.

Methamphetamine Increases Locomotion and Dopamine Transporter Activity in Dopamine D5 Receptor-Deficient Mice

M. Takada, I. Sora, T. Kodama, 2013, PloS one.

Monoamine transporter as a target molecule for psychostimulants.

I. Sora, K. Ikeda, H. Tomita, 2009, International review of neurobiology.

Activation of prefrontal parvalbumin interneurons ameliorates working memory deficit even under clinically comparable antipsychotic treatment in a mouse model of schizophrenia

K. Akiyama, Y. Arime, Noriaki Ohkawa, 2023, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.